Back to Search
Start Over
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD
- Source :
- Leukemia.
- Publication Year :
- 2023
- Publisher :
- Springer Science and Business Media LLC, 2023.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 14765551 and 08876924
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi...........470b4a4754ac0e8499a2f70639060e89
- Full Text :
- https://doi.org/10.1038/s41375-023-01901-4